The global angiography devices market is expected to reach a valuation of US$ 12,717.9 million in 2023. The expanding application and technology innovation scope is projected to be the market's primary growth drivers. The overall sales of angiography devices are projected to record a robust CAGR of 6.2% between 2023 and 2033, totaling around US$ 23,309.3 million by the end of 2033.
The conspicuous growth of the global healthcare industry's demand for accurate diagnosis and procedural equipment has positively influenced the consumption of angiography devices. Given the massive prevalence of cardiovascular diseases, the clamor for angiography devices is projected to rise further.
Medical and surgical technology advancements are assumed to contribute to the higher production of angiography devices. The precision of angiography devices may continue to influence their deployment by the world's leading medical organizations. Angiography devices, used to detect heart failures, may remain a significant trend in the global medical industry. As a result of this trend, the usage of angiography devices may grow exponentially, benefiting end-user well-being as well.
The high incidence of diseases such as cancer and CVDs, enhancing product approvals for sophisticated angiography techniques in the market, a substantial percentage of active research activities, burgeoning government and public-private investments, a growing amount of programs and initiatives, and high adoption of angiography devices due to the large angiography procedures performed globally all contribute to the market's development.
| Report Attributes or Data Points | Details |
|---|---|
| Global Angiography Devices Market Valuation in 2022 | US$ 12,116.7 million |
| Estimated Global Market Share in 2023 | US$ 12,717.9 million |
| Forecasted Global Market Size by 2033 | US$ 23,309.3 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 6.2% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 4.1% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights, global demand for angiography devices is assumed to rise at a CAGR of 6.2% between 2023 and 2033, which compares favorably to a 4.1% CAGR from 2018 to 2022. The extensive use of angiography devices in cardiometabolic therapeutic interventions may be a key factor driving the growth of the global angiography devices market.
Furthermore, the emergence of new and upgraded products is expected to supplement the market for angiography devices. The devices, anticipated to be available in the vast bulk of hospitals, are also used to mitigate the incidence rate of cardiac diseases. As a result, demand for angiography devices is expected to continue for decades, boosting the market growth during the forecast period.
Investments in the healthcare sector are escalating. The angiography devices market is also witnessing a surge in investment from government and non-government organizations. The increment of healthcare infrastructure in several countries may provide lucrative business potential growth.
Furthermore, beneficial federal regulations for certification in various developed regions are expected to fuel global market expansion. A reversal in preference toward minimally invasive procedures is also a racing requirement for angiography systems. Furthermore, rapid advancements in angiography equipment are improving diagnostic methods and are estimated to generate market growth.
If the device is damaged due to unforeseeable factors, the manufacturers do not reimburse or exchange the costs. Local medical facilities restrict the use of fragile angiography devices, lowering the diagnosis of cardiovascular diseases. The changing medical regulations necessitate the regular modernization of angiography devices, which confines the demand for existing or primitive devices and equipment. The high cost of angiography devices has resulted in the emergence of relatively cheap, inaccurate, and mendacious angiography equipment, which diversifies demand in the global angiography devices market.
Principal Consultant
North America remained dominant in the global market in terms of revenue, accumulating a 37.2% share in 2022. Because of the higher prevalence of cardiac diseases, the United States and Canada are projected to augment angiography devices. According to the American Heart Association (AHA), 45 percent of the United States population may experience at least one heart-related problem. It also predicts that the costs of cardiovascular diseases may soar by 100% between 2016 and 2035. Furthermore, a sophisticated healthcare system allows for the wider utilization of new and advanced angiography devices.
The FDA approved it in March 2020, permitting it to be launched in the United States market. Furthermore, at the Radiological Society of North America (RSNA) 2020 virtual meeting, GE Healthcare debuted the Allia IGS 7 angiography system. The system employs artificial intelligence to strengthen the use of rotational angiography. North America is expected to hold a global market share of 33% in 2022.
Besides that, according to a research paper titled 'Cardiac Catheterization Risks and Complications,' in 2021, cardiac catheterization surgical operations on an annual basis in the United States were 1,000,000. Thus, there is a greater necessity for coronary angiography devices in the United States, further expanding the overall market in North America.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 37.2% |
| Europe | 28.1% |
Asia Pacific is anticipated to grow substantially due to a spike in the volume of CVD cases, as well as greater investment in the region's healthcare system, which may result in the accessibility of necessary medical facilities. As per FMI, an average CAGR of 6% is anticipated for the Asia Pacific market.
In comparison to cardiac catheterization, Coronary Angiography has very elevated accuracy in detecting patients with coronary heart disease. As a result, there is an increase in demand for Coronary Angiography Devices in this region.
The Japanese administration's favorable reimbursement policies to promote technological breakthroughs are aiding and abetting the region's growth. In countries such as South Korea, Brazil, and India, the regulatory environment is less stringent, creating an intriguing opportunity for global companies to establish a presence in these markets. China is consolidating to improve the quality of this equipment. Rising imports from leading market players such as GE Healthcare, Siemens Healthcare, and Koninklijke Philips N.V. are propelling the China angiography market forward.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| United States | 34.1% |
| Germany | 8.2% |
| Japan | 8.3% |
The Europe market is anticipated to register a CAGR of around 5.2% between 2022 and 2032. Burgeoning minimally invasive surgical interventions, increased emphasis on research and development capabilities in medical devices and on the adoption of advanced healthcare technologies, an increase in robotic-assisted surgical procedures, and rising expenditure on healthcare infrastructure development are the key factors driving the growth of the market in this region.
Furthermore, in Europe, the unhealthy lifestyle of the working segment of society may cause a spike in heart ailments, inciting the growth of the angiography devices market. Europe held a global market share of 28.1% in 2022.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 5.9% |
| China | 8.3% |
| India | 7.7% |
| Australia | 5% |
Based on the device, MRA is anticipated to be the fastest-growing technology in the diagnosis of heart disease because of its minimal radiation exposure. MRA can acquire images in any anatomical plane with fantastic soft tissue contrast in 3D. The advent of 3.0T MR imaging has greatly improved the diagnosis of coronary artery disease. These factors are said to boost segment growth as well.
In 2019, the diagnostic application dominated the market. CTA and MRA advancements provide useful information not only in cardiology but also in neurology, such as cerebral aneurysms, acute stroke, brain arteriovenous malformation, dural arteriovenous fistula, suspected cerebral vasculitis, and occlusive diseases.
| Category | By Procedure |
|---|---|
| Top Segment | Coronary Angiography |
| Market Share in Percentage | 48.7% |
| Category | By End User |
|---|---|
| Top Segment | Hospitals and Surgical Centers |
| Market Share in Percentage | 61.1% |
Historically, based on the end-users segment, the hospitals, and surgical centers segment occupied the dominant share of the global market. This segment's growth can be attributed to the wide range of patients diagnosed and treated in hospitals, hospitals' high purchasing capacity for advanced technologies, the enormous percentage of diagnostic and therapeutic angiographic procedures, and growing recognition of the effects of timely disease diagnosis.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
Inorbvict Healthcare India Private Limited is a private company founded on August 21, 2014. It is headquartered in Pune, Maharashtra, India. They recently introduced a low-cost Angiography System to the market.
Some leading angiography device manufacturers include Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Cordis Corporation, Shimadzu Corporation, and Siemens Healthcare.
These key angiography device providers are adopting strategies, such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc., to increase their sales and gain a competitive edge in the global angiography devices market. For instance,
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.2% from 2023 to 2033 |
| Market Value in 2023 | US$ 12,717.9 million |
| Market Value in 2033 | US$ 23,309.3 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The growth potential of the angiography devices market is 6.2% CAGR through 2033.
The market is expected to be valued at US$ 23,309.3 million by 2033.
North America enjoys monopoly in the angiography devices market.
India and China dominate the Asian market.
Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, and Royal Philips Electronics are key market players.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Device, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Device, 2023 to 2033
5.3.1. Magnetic Resonance Angiography (MRA)
5.3.2. Computed Tomography Angiography (CTA)
5.3.3. Conventional
5.3.4. Digital Subtraction Angiography (DSA)
5.3.5. Catheter
5.3.6. Coronary
5.3.7. Other
5.4. Y-o-Y Growth Trend Analysis By Device, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Device, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure, 2023 to 2033
6.3.1. Coronary Angiography
6.3.2. Pulmonary Angiography
6.3.3. Cerebral Angiography
6.3.4. Extremity Angiography
6.3.5. Renal Angiography
6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals and Surgical Centres
7.3.2. Diagnostics Centres
7.3.3. Academic and Research Institutes
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
8.3.1. Coronary Artery Disease (CAD)
8.3.2. Congenital Heart Disease
8.3.3. Congestive Heart Failure
8.3.4. Kidney Disorders
8.3.5. Other Indications
8.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Device
10.2.3. By Procedure
10.2.4. By End User
10.2.5. By Indication
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device
10.3.3. By Procedure
10.3.4. By End User
10.3.5. By Indication
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Device
11.2.3. By Procedure
11.2.4. By End User
11.2.5. By Indication
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device
11.3.3. By Procedure
11.3.4. By End User
11.3.5. By Indication
11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Device
12.2.3. By Procedure
12.2.4. By End User
12.2.5. By Indication
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device
12.3.3. By Procedure
12.3.4. By End User
12.3.5. By Indication
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Device
13.2.3. By Procedure
13.2.4. By End User
13.2.5. By Indication
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Device
13.3.3. By Procedure
13.3.4. By End User
13.3.5. By Indication
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Device
14.2.3. By Procedure
14.2.4. By End User
14.2.5. By Indication
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Device
14.3.3. By Procedure
14.3.4. By End User
14.3.5. By Indication
14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Device
15.2.3. By Procedure
15.2.4. By End User
15.2.5. By Indication
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Device
15.3.3. By Procedure
15.3.4. By End User
15.3.5. By Indication
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Device
16.2.3. By Procedure
16.2.4. By End User
16.2.5. By Indication
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Device
16.3.3. By Procedure
16.3.4. By End User
16.3.5. By Indication
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Device
17.1.2.2. By Procedure
17.1.2.3. By End User
17.1.2.4. By Indication
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Device
17.2.2.2. By Procedure
17.2.2.3. By End User
17.2.2.4. By Indication
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Device
17.3.2.2. By Procedure
17.3.2.3. By End User
17.3.2.4. By Indication
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Device
17.4.2.2. By Procedure
17.4.2.3. By End User
17.4.2.4. By Indication
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Device
17.5.2.2. By Procedure
17.5.2.3. By End User
17.5.2.4. By Indication
17.6. UK
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Device
17.6.2.2. By Procedure
17.6.2.3. By End User
17.6.2.4. By Indication
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Device
17.7.2.2. By Procedure
17.7.2.3. By End User
17.7.2.4. By Indication
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Device
17.8.2.2. By Procedure
17.8.2.3. By End User
17.8.2.4. By Indication
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Device
17.9.2.2. By Procedure
17.9.2.3. By End User
17.9.2.4. By Indication
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Device
17.10.2.2. By Procedure
17.10.2.3. By End User
17.10.2.4. By Indication
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Device
17.11.2.2. By Procedure
17.11.2.3. By End User
17.11.2.4. By Indication
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Device
17.12.2.2. By Procedure
17.12.2.3. By End User
17.12.2.4. By Indication
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Device
17.13.2.2. By Procedure
17.13.2.3. By End User
17.13.2.4. By Indication
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Device
17.14.2.2. By Procedure
17.14.2.3. By End User
17.14.2.4. By Indication
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Device
17.15.2.2. By Procedure
17.15.2.3. By End User
17.15.2.4. By Indication
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Device
17.16.2.2. By Procedure
17.16.2.3. By End User
17.16.2.4. By Indication
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Device
17.17.2.2. By Procedure
17.17.2.3. By End User
17.17.2.4. By Indication
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Device
17.18.2.2. By Procedure
17.18.2.3. By End User
17.18.2.4. By Indication
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Device
17.19.2.2. By Procedure
17.19.2.3. By End User
17.19.2.4. By Indication
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Device
17.20.2.2. By Procedure
17.20.2.3. By End User
17.20.2.4. By Indication
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Device
17.21.2.2. By Procedure
17.21.2.3. By End User
17.21.2.4. By Indication
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2022
17.22.2.1. By Device
17.22.2.2. By Procedure
17.22.2.3. By End User
17.22.2.4. By Indication
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2022
17.23.2.1. By Device
17.23.2.2. By Procedure
17.23.2.3. By End User
17.23.2.4. By Indication
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Device
18.3.3. By Procedure
18.3.4. By End User
18.3.5. By Indication
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Abbott Vascular (Abbott Laboratories)
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Toshiba Medical Systems Corporation
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Royal Philips Electronics
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. GE Healthcare
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. Medtronic
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Cordis Corporation
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Shimadzu Corporation
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Siemens Healthcare.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. Canon Medical Systems
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. St. Jude Medical Inc.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Healthcare
June 2023
REP-GB-12575
220 pages
Explore Healthcare Insights
View Reports
Angiography Devices Market
